1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Asthma Treatment Market
2.3. Global Asthma Treatment Market, By Drug Class, 2025 (US$ Million)
2.4. Global Asthma Treatment Market, By Product, 2025 (US$ Million)
2.5. Global Asthma Treatment Market, By Route of Administration, 2025 (US$ Million)
2.6. Global Asthma Treatment Market, By Treatment Type, 2025 (US$ Million)
2.7. Global Asthma Treatment Market, By Geography, 2025 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2025
3. Asthma Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Asthma Treatment Market Vendors
3.2. Strategies Adopted by Asthma Treatment Market Vendors
4. Asthma Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Asthma Treatment Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Anti-inflammatory
5.3.2. Bronchodilators
5.3.3. Combination Therapy
6. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Inhalers
6.3.1.1. Dry powder inhalers
6.3.1.2. Metered dose inhalers
6.3.1.3. Soft mist inhalers
6.3.2. Nebulizers
7. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Oral
7.3.2. Inhaled
7.3.3. Others
8. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2025 Versus 2034
8.3. Market Segmentation
8.3.1. Long-term Asthma Control Medications
8.3.2. Quick-relief (Rescue) Medications
9. North America Asthma Treatment Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
9.3. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
9.4. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
9.5. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
9.6. Asthma Treatment Market: By Region, 2024-2034, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
9.6.1.1.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
9.6.1.1.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
9.6.1.1.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
9.6.1.2.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
9.6.1.2.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
9.6.1.2.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
9.6.1.3.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
9.6.1.3.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
9.6.1.3.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10. UK and European Union Asthma Treatment Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.3. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
10.4. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.5. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6. Asthma Treatment Market: By Region, 2024-2034, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.6.1.1.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
10.6.1.1.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.6.1.1.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.6.1.2.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
10.6.1.2.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.6.1.2.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.6.1.3.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
10.6.1.3.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.6.1.3.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.6.1.4.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
10.6.1.4.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.6.1.4.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.5. France
10.6.1.5.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.6.1.5.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
10.6.1.5.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.6.1.5.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
10.6.1.6.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
10.6.1.6.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
10.6.1.6.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11. Asia Pacific Asthma Treatment Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.3. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
11.4. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.5. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6. Asthma Treatment Market: By Region, 2024-2034, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.6.1.1.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
11.6.1.1.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.6.1.1.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.6.1.2.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
11.6.1.2.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.6.1.2.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.3. India
11.6.1.3.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.6.1.3.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
11.6.1.3.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.6.1.3.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.6.1.4.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
11.6.1.4.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.6.1.4.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.6.1.5.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
11.6.1.5.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.6.1.5.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
11.6.1.6.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
11.6.1.6.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
11.6.1.6.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
12. Latin America Asthma Treatment Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.3. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
12.4. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.5. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
12.6. Asthma Treatment Market: By Region, 2024-2034, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.6.1.1.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
12.6.1.1.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.6.1.1.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.6.1.2.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
12.6.1.2.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.6.1.2.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
12.6.1.3.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
12.6.1.3.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
12.6.1.3.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
13. Middle East and Africa Asthma Treatment Market, 2024-2034, USD (Million)
13.1. Market Overview
13.2. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
13.3. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
13.4. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
13.5. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
13.6. Asthma Treatment Market: By Region, 2024-2034, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
13.6.1.1.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
13.6.1.1.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
13.6.1.1.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
13.6.1.2.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
13.6.1.2.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
13.6.1.2.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Asthma Treatment Market: By Drug Class, 2024-2034, USD (Million)
13.6.1.3.2. Asthma Treatment Market: By Product, 2024-2034, USD (Million)
13.6.1.3.3. Asthma Treatment Market: By Route of Administration, 2024-2034, USD (Million)
13.6.1.3.4. Asthma Treatment Market: By Treatment Type, 2024-2034, USD (Million)
14. Company Profile
14.1. GlaxoSmithKline plc (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
14.2. AstraZeneca
14.3. Boehringer Ingelheim International GmbH
14.4. Mylan N.V
14.5. F. Hoffmann-La Roche Ltd.
14.6. Lupin Pharmaceuticals
14.7. Glenmark Pharmaceuticals
14.8. Merck & Co. Inc.
14.9. Novartis International AG
14.10. Sanofi
14.11. Sunovion Pharmaceuticals, Inc.
14.12. Teva Pharmaceutical Industries
14.13. Other Notable Players
